Company Directory / research

PrivateFor profitresearchWuxi, China
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
Size
1-10 people: larger than 0% of companies with a size listed
Age
6 years old.
Reach
No web traffic ranking listed.
BiotechnologyLife SciencePharmaceutical
Funding, as listed
$262M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about D3 Bio, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
D3 Bio may be growing as it has recently appointed a new independent board member, which could indicate a strategic move to strengthen its governance and expertise in the biotechnology industry. Additionally, the company has secured a significant investment of $40 million from VC firm Medicxi, which suggests confidence from investors in D3 Bio's potential and could support further research and development activities. The appointment and investment are indicative of an expansion in both the company's leadership and financial resources.
Summaries written by the source dataset, not by us, and not checked.
research in China.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 38,667 companies in China and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.